i
Loading Page
loading, please wait

Select Year:

Home > PA Providers
placeholder image of provider

Dr. Mark Scott Morginstin, DO

Accepting New Patients
Specializes in: Medical Oncology, Adult Oncology and Adult Hematology
Rowan University School of Osteopathic Medicine (1996)
Professional interests include: thyroid cancer, liver cancer, larynx cancer, and more.
5501 Old York Road Floor 1
Philadelphia, PA 19141

Dr. Mark Scott Morginstin, DO is a medical oncologist in Philadelphia, PA specializing in medical oncology, adult oncology and adult hematology. He graduated from Rowan University School of Osteopathic Medicine in 1996 and has 30 years of experience. Dr. Mark Scott Morginstin, DO is affiliated with Jefferson Health, Jefferson Einstein Philadelphia Hospital, Jefferson Einstein Montgomery Hospital and EINSTEIN PRACTICE PLAN INC.

View Doctor's Full Profile (215) 456-3930

Office Locations

5501 Old York Road Floor 1
Philadelphia, PA 19141
open_in_new
609 West Germantown Pike
East Norriton, PA 19403
open_in_new

Some issues Dr. Mark Scott Morginstin, DO can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

Thyroid Problems

Thyroid problems are a group of conditions that alter hormone regulation and metabolism. The thyroid is a small, butterfly-shaped gland located in the lower neck, just below the Adam's apple (laryngeal prominence) and larynx (voice box). Despite its small size, the thyroid has an outsized effect on the body by regulating hormones that control metabolism. Metabolism is the body's process of converting consumed food into fuel to power the entire body. Heart rate, weight, cholesterol, body temperature, and even physical growth and development are all affected by the metabolism.

When the thyroid malfunctions, the body is unable to properly process and allocate energy. Thyroid problems, such as hyperthyroidism (overactive thyroid) and hypothyroidism (underactive thyroid), cause irregular metabolism. In some cases, the body produces antibodies that attack the thyroid cells for unknown reasons. The damaged thyroid responds by releasing either too little or too much T3 and T4 thyroid hormones. Thyroid malfunctions may also arise from genetic causes or iodine deficiency. Thyroid problems may include:

  • Hashimoto's thyroiditis, an autoimmune disease that causes hypothyroidism
  • Graves' disease, an autoimmune disease that causes hyperthyroidism
  • Goiter
  • Thyroid nodule
  • Thyroid cancer

Hashimoto's is the leading cause of hypothyroidism, which is when the thyroid does not produce enough hormones to stimulate adequate metabolism. The condition is diagnosed by blood tests that measure TSH (thyroid stimulating hormone) and detect Hashimoto's antibodies. Symptoms of hypothyroidism include sluggish metabolism, inflammation, fatigue, weight gain, brittle hair, dry skin, and sensitivity to cold. To supplement impaired thyroid function, patients with Hashimoto's are typically prescribed synthetic thyroid hormone pills. Such patients may need to consume synthetic thyroids for the rest of their lives. Other treatments may include dietary changes, such as the avoidance of certain foods and medication to reduce inflammation. Frequent blood tests can inform patients if their TSH levels are within a normal range.

Grave's disease is most frequently the cause of hyperthyroidism, which is when the thyroid produces too many hormones, overstimulating one's metabolism. The condition is also diagnosed by blood tests that measure TSH and detect Grave's antibodies. Elevated heart rate, high blood pressure, sweating, bulging eyes, and weight loss are common symptoms of hyperthyroidism. Treatments for hyperthyroidism include oral radioactive iodine, which slowly shrinks the thyroid, slowing the production of excess thyroid hormone. Other anti-thyroid medications such as methimazole (Tapazole) also reduce the production of thyroid hormones. Blood pressure medications known as beta blockers can ease the increased heart rate caused by hyperthyroidism. If treatments are unsuccessful, patients may be prescribed a thyroidectomy, or surgery to remove part or all of the thyroid. Some patients with hyperthyroidism may require ophthalmological (eye medicine) treatments such as eye drops, prednisone, and surgery to reduce eye swelling and bulging.

Untreated thyroid disorders frequently lead to goiters or thyroid nodules. A thyroid goiter is a large lump that can be felt near the base of the neck and is made of swollen thyroid tissue or nodules (excess cell growth). Nodules and goiters are diagnosed by CT scan or ultrasound. Obstructive goiters can cause pain, coughing, and abnormal breathing. The most common cause of goiters is hyperthyroidism (overactive thyroid). However, Hashimoto's is also known to cause goiters or nodules. Goiters develop from continued damage from antibodies to the thyroid over time. At times, a goiter can result from a cancerous thyroid tumor. Most goiters and nodules are themselves benign.

The exact causes of thyroid cancer are unknown. People who develop thyroid cancer may or may not have another thyroid problem such as Hashimoto's or Grave's disease. Symptoms of thyroid cancer include a nodule that can be felt on the neck, hoarseness, difficulty swallowing, swelling in the neck, and neck and throat pain. CT and MRI scans are used to diagnose thyroid cancer. There are four types of thyroid cancer which vary in intensity. Thyroidectomy (thyroid removal surgery) is usually prescribed to treat thyroid cancer.

Thyroid problems are often long-term conditions that require some form of treatment. With regular monitoring and medication, many people with thyroid problems are able to lead active and fulfilling lives.

Noteworthy Medicare Patient Procedures Performed by Dr. Mark Scott Morginstin, DO in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 25%

By Affordability:

hospital care
inpatient care
inpatient hospital care

In 2012, Dr. Mark Scott Morginstin, DO had a list price for hospital care, inpatient care, and inpatient hospital care (for patient admitted to hospital) that was lower than the list prices billed to Medicare by 75% of providers in related specialties within Pennsylvania. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2012 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 370
hospital care 142
inpatient care 142

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2013 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 446
hospital care 201
inpatient care 201

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 121
Female 199
Ethnicity
Non-Hispanic White 162
Black 137
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 132
From 75 to 84 58
85 and over 44
Less than 65 86

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2013

Hypertension 75
High Cholesterol 50
Stroke 11
Ischemic Heart Disease 43
Depression 28
Chronic Kidney Disease 39
Asthma 9
Osteoperosis 7
Atrial Fibrilation 14
Heart Failure 37
Chronic Obstructive Pulmonary Disease 21
Diabetes 41
Dementia 15
Cancer 51

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2014 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 463
hospital care 176
inpatient care 176

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 102
Female 215
Ethnicity
Non-Hispanic White 158
Black 130
Hispanic 17
Asian 0
Other 0
Native American 0
Age
From 65 to 74 145
From 75 to 84 61
85 and over 35
Less than 65 76

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2014

Hypertension 75
High Cholesterol 58
Stroke 9
Ischemic Heart Disease 38
Depression 24
Chronic Kidney Disease 35
Asthma 6
Osteoperosis 9
Atrial Fibrilation 10
Heart Failure 28
Chronic Obstructive Pulmonary Disease 17
Diabetes 47
Dementia 14
Cancer 59

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2015 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 388
hospital care 191
inpatient care 191

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 172
Female 478
Ethnicity
Non-Hispanic White 302
Black 298
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 258
From 75 to 84 132
85 and over 72
Less than 65 188

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2015

Hypertension 75
High Cholesterol 60
Stroke 10
Ischemic Heart Disease 40
Depression 29
Chronic Kidney Disease 37
Asthma 12
Osteoperosis 10
Atrial Fibrilation 10
Heart Failure 27
Chronic Obstructive Pulmonary Disease 20
Diabetes 46
Dementia 14
Cancer 63

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2016 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 451
hospital care 169
inpatient care 169

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 91
Female 263
Ethnicity
Non-Hispanic White 164
Black 158
Hispanic 17
Asian 0
Other 0
Native American 0
Age
From 65 to 74 160
From 75 to 84 76
85 and over 33
Less than 65 85

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2016

Hypertension 75
High Cholesterol 60
Stroke 8
Ischemic Heart Disease 43
Depression 28
Chronic Kidney Disease 42
Asthma 24
Osteoperosis 13
Atrial Fibrilation 12
Heart Failure 25
Chronic Obstructive Pulmonary Disease 18
Diabetes 42
Dementia 14
Cancer 65

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2017 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 429
hospital care 166
inpatient care 166

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 102
Female 243
Ethnicity
Non-Hispanic White 156
Black 164
Hispanic 12
Asian 0
Other 0
Native American 0
Age
From 65 to 74 140
From 75 to 84 81
85 and over 35
Less than 65 89

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2017

Hypertension 75
High Cholesterol 57
Stroke 10
Ischemic Heart Disease 45
Depression 24
Chronic Kidney Disease 47
Asthma 10
Osteoperosis 11
Atrial Fibrilation 10
Heart Failure 27
Chronic Obstructive Pulmonary Disease 19
Diabetes 45
Dementia 12
Cancer 54

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2018 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 540
hospital care 168
inpatient care 168

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 140
Female 266
Ethnicity
Non-Hispanic White 194
Black 172
Hispanic 20
Asian 0
Other 0
Native American 0
Age
From 65 to 74 166
From 75 to 84 105
85 and over 41
Less than 65 94

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2018

Hypertension 75
High Cholesterol 64
Stroke 9
Ischemic Heart Disease 47
Depression 26
Chronic Kidney Disease 48
Asthma 10
Osteoperosis 13
Atrial Fibrilation 11
Heart Failure 29
Chronic Obstructive Pulmonary Disease 21
Diabetes 42
Dementia 15
Cancer 53

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2019 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 629
hospital care 120
inpatient care 120

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 141
Female 254
Ethnicity
Non-Hispanic White 248
Black 120
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 169
From 75 to 84 113
85 and over 48
Less than 65 65

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2019

Hypertension 75
High Cholesterol 67
Stroke 11
Ischemic Heart Disease 49
Depression 29
Chronic Kidney Disease 45
Asthma 10
Osteoperosis 12
Atrial Fibrilation 17
Heart Failure 26
Chronic Obstructive Pulmonary Disease 18
Diabetes 39
Dementia 14
Cancer 51

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2020 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 511
hospital care 128
inpatient care 128

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 167
Female 260
Ethnicity
Non-Hispanic White 293
Black 105
Hispanic 16
Asian 0
Other 0
Native American 0
Age
From 65 to 74 162
From 75 to 84 143
85 and over 59
Less than 65 63

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2020

Hypertension 75
High Cholesterol 69
Stroke 8
Ischemic Heart Disease 55
Depression 27
Chronic Kidney Disease 51
Asthma 9
Osteoperosis 12
Atrial Fibrilation 17
Heart Failure 28
Chronic Obstructive Pulmonary Disease 19
Diabetes 42
Dementia 16
Cancer 53

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2021 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 587
hospital care 116
inpatient care 116

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 159
Female 217
Ethnicity
Non-Hispanic White 259
Black 92
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 153
From 75 to 84 126
85 and over 54
Less than 65 43

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2021

Hypertension 75
High Cholesterol 65
Stroke 10
Ischemic Heart Disease 51
Depression 22
Chronic Kidney Disease 51
Asthma 7
Osteoperosis 11
Atrial Fibrilation 17
Heart Failure 28
Chronic Obstructive Pulmonary Disease 18
Diabetes 38
Dementia 14
Cancer 47

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA during 2022 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

doctor visit 560
hospital care 120
inpatient care 120

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 136
Female 205
Ethnicity
Non-Hispanic White 258
Black 55
Hispanic 0
Asian 0
Other 12
Native American 0
Age
From 65 to 74 132
From 75 to 84 132
85 and over 46
Less than 65 31

Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO in 2022

Hypertension 75
High Cholesterol 75
Stroke 12
Ischemic Heart Disease 40
Depression 23
Chronic Kidney Disease 32
Asthma 10
Osteoperosis 13
Atrial Fibrilation 20
Heart Failure 21
Chronic Obstructive Pulmonary Disease 22
Diabetes 37
Dementia 9
Cancer 52

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Mark Scott Morginstin, DO for Medicare patients.

The highest averages for the top procedures that Dr. Mark Scott Morginstin, DO treated as a medical oncologist in Philadelphia, PA were hospital care and inpatient care.

doctor visit 488
hospital care 154
inpatient care 154

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Mark Scott Morginstin, DO.

Gender
Male 121
Female 236
Ethnicity
Black / African American 130
Asian / Pacific Islander 0
Non-Hispanic White 199
Hispanic 7
Native American / Alaskan Native 0
Other 1
Age
75 to 84 93
85 and over 42
Less than 65 74
65 to 74 147

Average of Total of Conditions of Medicare patients treated by Dr. Mark Scott Morginstin, DO From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Mark Scott Morginstin, DO treated were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension 68
High Cholesterol 56
Stroke 8
Ischemic Heart Disease 41
Depression 23
Chronic Kidney Disease 38
Asthma 9
Osteoporosis 10
Heart Failure 25
Chronic Obstructive Pulmonary Disease 17
Diabetes 38
Atrial Fibrillation 12
Cancer 49
Dementia 12

Education & Training

Dr. Mark Scott Morginstin, DO graduated from Rowan University School of Osteopathic Medicine in 1996. He is certified by the Board Certification: Hematology and has a state license in Connecticut.

Medical School: Rowan University School of Osteopathic Medicine (1996)

Board Certification: Board Certification: Hematology

Licensed In: Connecticut

Affiliations & Hospitals

Dr. Mark Scott Morginstin, DO is associated with these hospitals and organizations:

Jefferson Health
Jefferson Einstein Philadelphia Hospital
Jefferson Einstein Montgomery Hospital
EINSTEIN PRACTICE PLAN INC

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Mark Scott Morginstin, DO appears to accept the following insurance providers: QualCare, Aetna Medicare, CIGNA Medicare, Highmark Blue Cross Blue Shield, Blue Cross Federal, Horizon Blue Cross Blue Shield, GEHA, WellCare, AmeriHealth, AARP, MultiPlan, Independence Blue Cross, Geisinger Health Plan, US Family Health Plan, Amerigroup, United Healthcare, Medicaid, Humana, Devon Health, TRICARE, First Health, WellPoint, Medical Assistance of New Jersey, Provider Partners Medicare, PA Health and Wellness CHC, Devoted Medicare, Jefferson Health Plans Medicare and Marketplace (formerly Health Partners Plans), Motor Vehicle Insurance, Medical Assistance of Delaware, Keystone First/CHC/VIP, Blue Card by BCBS, Medicare FFS, Medical Assistance of Pennsylvania, Aetna Commercial - Excludes Marketplace Plans, UPMC, Highmark Wholecare (Medicare only), Aetna Better Health CHIP PA, Ambetter from PA Health and Wellness and Keystone First VIP.

Insurance Accepted by Provider includes:

According to our sources, Dr. Mark Scott Morginstin, DO accepts the following insurance providers:

QualCare
Aetna Medicare
CIGNA Medicare
Highmark Blue Cross Blue Shield
Blue Cross Federal
Horizon Blue Cross Blue Shield
GEHA
WellCare
AmeriHealth
AARP
MultiPlan
Independence Blue Cross
Geisinger Health Plan
US Family Health Plan
Amerigroup
United Healthcare
Medicaid
Humana
Devon Health
TRICARE
First Health
WellPoint
Medical Assistance of New Jersey
Provider Partners Medicare
PA Health and Wellness CHC
Devoted Medicare
Jefferson Health Plans Medicare and Marketplace (formerly Health Partners Plans)
Motor Vehicle Insurance
Medical Assistance of Delaware
Keystone First/CHC/VIP
Blue Card by BCBS
Medicare FFS
Medical Assistance of Pennsylvania
Aetna Commercial - Excludes Marketplace Plans
UPMC
Highmark Wholecare (Medicare only)
Aetna Better Health CHIP PA
Ambetter from PA Health and Wellness
Keystone First VIP

Ratings & Reviews

Dr. Mark Scott Morginstin, DO has an exceptional overall rating with an average of 4.91 out of 5 stars based on 1151 ratings. We collect ratings and reviews of Dr. Mark Scott Morginstin, DO from all over the web to help you find the right in Philadelphia, PA. 

4.91
Overall Rating
Leave a Review

General Payments

These charts describe general payments received by Dr. Mark Scott Morginstin, DO. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Payments by Company
EISAI INC. $150 Halaven
$105 		Lenvima
$24 		ALOXI
$21
Celgene Corporation $92 Abraxane
$69 		Pomalyst
$23
Genentech USA, Inc. $73 Kadcyla
$36 		Phesgo
$25 		TECENTRIQ
$12
AstraZeneca Pharmaceuticals LP $70 FASLODEX
$59 		CALQUENCE
$11
SANOFI-AVENTIS U.S. LLC $42 JEVTANA
$28 		ZALTRAP
$14
Other $258 ZEJULA
$38 		OPDIVO
$21 		BAVENCIO
$21 		VERZENIO
$17 		XOSPATA
$17 		Other
$144
Types of Payments
Food and Beverage $674
Education $12

Research Payments

Dr. Mark Scott Morginstin, DO has received 27 research payments totaling $74,964.

Biography

Dr. Mark Morginstin specializes in adult hematology, adult oncology, and medical oncology and practices in Philadelphia, PA and East Norriton, PA. Patient reviews placed him at an average of 5.0 stars (out of 5). His clinical interests include bladder cancer, idiopathic thrombocytopenic purpura (ITP), and appendix cancer. Dr. Morginstin usually is in-network for Amerigroup, Blue California, and Coventry, as well as other insurance carriers. He graduated from Rowan University School of Osteopathic Medicine and UMDNJ-Robert Wood Johnson Medical School. Dr. Morginstin is professionally affiliated with Jefferson Health. He welcomes new patients at his office inEast Norriton, PA as reported by Jefferson Health.

Other Providers in Philadelphia, PA